InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（5 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
5
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Noblett Karen, Directeur Médical. Officer active across 1 company, notably Axonics, Inc.. Aggregated, 11 reports have been published. Breakdown: 0 buy · 5 sells. Total volume traded: €5m. Activity tracked since 31 January 2022. The latest transaction was disclosed on 15 November 2024 (Disposition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Noblett Karen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
34,428 股@ US$71.0029.2% 占其流量Common StockSEC:0001562180-24-007708:0
27,500 股0Common StockSEC:0001562180-24-001013:0
15,999 股@ US$69.001912.7% 占其流量Common StockSEC:0001562180-24-000425:0
949 股@ US$63.000.7% 占其流量Common StockSEC:0001562180-23-008578:0
5,000 股0Common StockSEC:0001562180-23-000872:0
18,519 股@ US$14.193.3% 占其流量Common StockSEC:0001562180-22-006777:0
13,964 股@ US$25.824.5% 占其流量Common StockSEC:0001562180-22-006777:1
32,483 股@ US$78.157831.5% 占其流量Common StockSEC:0001562180-22-006777:2
10,454 股@ US$71.53199.4% 占其流量Common StockSEC:0001562180-22-006605:0
13,531 股@ US$57.22858.8% 占其流量Common StockSEC:0001562180-22-002872:0
5,350 股0Common StockSEC:0001562180-22-001109:0
11 条申报中的 11 条
About Noblett Karen
Noblett Karen is Director Médical and reports transactions in Axonics, Inc. (XNAS), where she is Chief Medical Officer. She has filed 11 forms in total, and across the 11 recent sampled filings the activity consists only of sales, with EUR 7,336,584 of sell-side volume between 2022-02-03 and 2024-11-15.
